CDIO vs. MLGO, TRIB, SAI, BMRA, OCX, MYMD, MCAG, AWH, ICCC, and ABIO
Should you be buying Cardio Diagnostics stock or one of its competitors? The main competitors of Cardio Diagnostics include MicroAlgo (MLGO), Trinity Biotech (TRIB), SAI.TECH Global (SAI), Biomerica (BMRA), OncoCyte (OCX), MyMD Pharmaceuticals (MYMD), Mountain Crest Acquisition Corp. V (MCAG), Aspira Women's Health (AWH), ImmuCell (ICCC), and ARCA biopharma (ABIO).
Cardio Diagnostics (NASDAQ:CDIO) and MicroAlgo (NASDAQ:MLGO) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, community ranking, earnings, analyst recommendations, dividends, profitability, media sentiment, institutional ownership and valuation.
Cardio Diagnostics has a beta of 5.3, indicating that its stock price is 430% more volatile than the S&P 500. Comparatively, MicroAlgo has a beta of 0.87, indicating that its stock price is 13% less volatile than the S&P 500.
Cardio Diagnostics currently has a consensus price target of $1.35, suggesting a potential upside of 56.99%. Given Cardio Diagnostics' higher possible upside, equities research analysts clearly believe Cardio Diagnostics is more favorable than MicroAlgo.
Cardio Diagnostics has higher earnings, but lower revenue than MicroAlgo.
8.1% of Cardio Diagnostics shares are owned by institutional investors. Comparatively, 1.1% of MicroAlgo shares are owned by institutional investors. 30.0% of Cardio Diagnostics shares are owned by insiders. Comparatively, 22.7% of MicroAlgo shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Cardio Diagnostics received 2 more outperform votes than MicroAlgo when rated by MarketBeat users.
MicroAlgo's return on equity of 0.00% beat Cardio Diagnostics' return on equity.
In the previous week, Cardio Diagnostics had 3 more articles in the media than MicroAlgo. MarketBeat recorded 5 mentions for Cardio Diagnostics and 2 mentions for MicroAlgo. MicroAlgo's average media sentiment score of 0.96 beat Cardio Diagnostics' score of 0.79 indicating that MicroAlgo is being referred to more favorably in the news media.
Summary
Cardio Diagnostics beats MicroAlgo on 9 of the 13 factors compared between the two stocks.
Get Cardio Diagnostics News Delivered to You Automatically
Sign up to receive the latest news and ratings for CDIO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CDIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cardio Diagnostics Competitors List
Related Companies and Tools
